Home » Topics » Regulatory

Regulatory
RSS

New once-daily antihypertensive combination available in U.S.

Feb. 18, 1998

New formulation of FK-506 demonstrates superior efficacy

Feb. 17, 1998

IND approved for new formulation of lidocaine

Feb. 17, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

FDA approves CellCept for new indication

Feb. 16, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Solvay and Elan to codevelop new formulation of fluvoxamine

Feb. 10, 1998

Lovenox approved for at-home use in U.S.

Feb. 9, 1998

Promising laboratory findings and phase I results reported for Leukine

Feb. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...